1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Membrane-bound Proteins
1.2.3 Soluble Proteins
1.2.4 Noncoding RNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Diagnostic Exosome Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Exosome Biomarker Market Perspective (2017-2028)
2.2 Diagnostic Exosome Biomarker Growth Trends by Region
2.2.1 Diagnostic Exosome Biomarker Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diagnostic Exosome Biomarker Historic Market Size by Region (2017-2022)
2.2.3 Diagnostic Exosome Biomarker Forecasted Market Size by Region (2023-2028)
2.3 Diagnostic Exosome Biomarker Market Dynamics
2.3.1 Diagnostic Exosome Biomarker Industry Trends
2.3.2 Diagnostic Exosome Biomarker Market Drivers
2.3.3 Diagnostic Exosome Biomarker Market Challenges
2.3.4 Diagnostic Exosome Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Exosome Biomarker Players by Revenue
3.1.1 Global Top Diagnostic Exosome Biomarker Players by Revenue (2017-2022)
3.1.2 Global Diagnostic Exosome Biomarker Revenue Market Share by Players (2017-2022)
3.2 Global Diagnostic Exosome Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Exosome Biomarker Revenue
3.4 Global Diagnostic Exosome Biomarker Market Concentration Ratio
3.4.1 Global Diagnostic Exosome Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Exosome Biomarker Revenue in 2021
3.5 Diagnostic Exosome Biomarker Key Players Head office and Area Served
3.6 Key Players Diagnostic Exosome Biomarker Product Solution and Service
3.7 Date of Enter into Diagnostic Exosome Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Exosome Biomarker Breakdown Data by Type
4.1 Global Diagnostic Exosome Biomarker Historic Market Size by Type (2017-2022)
4.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2023-2028)
5 Diagnostic Exosome Biomarker Breakdown Data by Application
5.1 Global Diagnostic Exosome Biomarker Historic Market Size by Application (2017-2022)
5.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diagnostic Exosome Biomarker Market Size (2017-2028)
6.2 North America Diagnostic Exosome Biomarker Market Size by Type
6.2.1 North America Diagnostic Exosome Biomarker Market Size by Type (2017-2022)
6.2.2 North America Diagnostic Exosome Biomarker Market Size by Type (2023-2028)
6.2.3 North America Diagnostic Exosome Biomarker Market Share by Type (2017-2028)
6.3 North America Diagnostic Exosome Biomarker Market Size by Application
6.3.1 North America Diagnostic Exosome Biomarker Market Size by Application (2017-2022)
6.3.2 North America Diagnostic Exosome Biomarker Market Size by Application (2023-2028)
6.3.3 North America Diagnostic Exosome Biomarker Market Share by Application (2017-2028)
6.4 North America Diagnostic Exosome Biomarker Market Size by Country
6.4.1 North America Diagnostic Exosome Biomarker Market Size by Country (2017-2022)
6.4.2 North America Diagnostic Exosome Biomarker Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Diagnostic Exosome Biomarker Market Size (2017-2028)
7.2 Europe Diagnostic Exosome Biomarker Market Size by Type
7.2.1 Europe Diagnostic Exosome Biomarker Market Size by Type (2017-2022)
7.2.2 Europe Diagnostic Exosome Biomarker Market Size by Type (2023-2028)
7.2.3 Europe Diagnostic Exosome Biomarker Market Share by Type (2017-2028)
7.3 Europe Diagnostic Exosome Biomarker Market Size by Application
7.3.1 Europe Diagnostic Exosome Biomarker Market Size by Application (2017-2022)
7.3.2 Europe Diagnostic Exosome Biomarker Market Size by Application (2023-2028)
7.3.3 Europe Diagnostic Exosome Biomarker Market Share by Application (2017-2028)
7.4 Europe Diagnostic Exosome Biomarker Market Size by Country
7.4.1 Europe Diagnostic Exosome Biomarker Market Size by Country (2017-2022)
7.4.2 Europe Diagnostic Exosome Biomarker Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size (2017-2028)
8.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type
8.2.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diagnostic Exosome Biomarker Market Share by Type (2017-2028)
8.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application
8.3.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Diagnostic Exosome Biomarker Market Share by Application (2017-2028)
8.4 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region
8.4.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diagnostic Exosome Biomarker Market Size (2017-2028)
9.2 Latin America Diagnostic Exosome Biomarker Market Size by Type
9.2.1 Latin America Diagnostic Exosome Biomarker Market Size by Type (2017-2022)
9.2.2 Latin America Diagnostic Exosome Biomarker Market Size by Type (2023-2028)
9.2.3 Latin America Diagnostic Exosome Biomarker Market Share by Type (2017-2028)
9.3 Latin America Diagnostic Exosome Biomarker Market Size by Application
9.3.1 Latin America Diagnostic Exosome Biomarker Market Size by Application (2017-2022)
9.3.2 Latin America Diagnostic Exosome Biomarker Market Size by Application (2023-2028)
9.3.3 Latin America Diagnostic Exosome Biomarker Market Share by Application (2017-2028)
9.4 Latin America Diagnostic Exosome Biomarker Market Size by Country
9.4.1 Latin America Diagnostic Exosome Biomarker Market Size by Country (2017-2022)
9.4.2 Latin America Diagnostic Exosome Biomarker Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size (2017-2028)
10.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type
10.2.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diagnostic Exosome Biomarker Market Share by Type (2017-2028)
10.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application
10.3.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Diagnostic Exosome Biomarker Market Share by Application (2017-2028)
10.4 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country
10.4.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 101Bio
11.1.1 101Bio Company Details
11.1.2 101Bio Business Overview
11.1.3 101Bio Diagnostic Exosome Biomarker Introduction
11.1.4 101Bio Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.1.5 101Bio Recent Developments
11.2 AMS Biotechnology
11.2.1 AMS Biotechnology Company Details
11.2.2 AMS Biotechnology Business Overview
11.2.3 AMS Biotechnology Diagnostic Exosome Biomarker Introduction
11.2.4 AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.2.5 AMS Biotechnology Recent Developments
11.3 BioRegenerative Sciences
11.3.1 BioRegenerative Sciences Company Details
11.3.2 BioRegenerative Sciences Business Overview
11.3.3 BioRegenerative Sciences Diagnostic Exosome Biomarker Introduction
11.3.4 BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.3.5 BioRegenerative Sciences Recent Developments
11.4 Cell Guidance Systems
11.4.1 Cell Guidance Systems Company Details
11.4.2 Cell Guidance Systems Business Overview
11.4.3 Cell Guidance Systems Diagnostic Exosome Biomarker Introduction
11.4.4 Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.4.5 Cell Guidance Systems Recent Developments
11.5 Codiak BioSciences
11.5.1 Codiak BioSciences Company Details
11.5.2 Codiak BioSciences Business Overview
11.5.3 Codiak BioSciences Diagnostic Exosome Biomarker Introduction
11.5.4 Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.5.5 Codiak BioSciences Recent Developments
11.6 Evomic Science
11.6.1 Evomic Science Company Details
11.6.2 Evomic Science Business Overview
11.6.3 Evomic Science Diagnostic Exosome Biomarker Introduction
11.6.4 Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.6.5 Evomic Science Recent Developments
11.7 ExoCyte Therapeutics
11.7.1 ExoCyte Therapeutics Company Details
11.7.2 ExoCyte Therapeutics Business Overview
11.7.3 ExoCyte Therapeutics Diagnostic Exosome Biomarker Introduction
11.7.4 ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.7.5 ExoCyte Therapeutics Recent Developments
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne Diagnostic Exosome Biomarker Introduction
11.8.4 Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.8.5 Bio-Techne Recent Developments
11.9 Exovita biosciences
11.9.1 Exovita biosciences Company Details
11.9.2 Exovita biosciences Business Overview
11.9.3 Exovita biosciences Diagnostic Exosome Biomarker Introduction
11.9.4 Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.9.5 Exovita biosciences Recent Developments
11.10 Immune Therapy Holdings
11.10.1 Immune Therapy Holdings Company Details
11.10.2 Immune Therapy Holdings Business Overview
11.10.3 Immune Therapy Holdings Diagnostic Exosome Biomarker Introduction
11.10.4 Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.10.5 Immune Therapy Holdings Recent Developments
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Diagnostic Exosome Biomarker Introduction
11.11.4 Lonza Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.11.5 Lonza Recent Developments
11.12 Norgen Biotek
11.12.1 Norgen Biotek Company Details
11.12.2 Norgen Biotek Business Overview
11.12.3 Norgen Biotek Diagnostic Exosome Biomarker Introduction
11.12.4 Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.12.5 Norgen Biotek Recent Developments
11.13 ReNeuron Group
11.13.1 ReNeuron Group Company Details
11.13.2 ReNeuron Group Business Overview
11.13.3 ReNeuron Group Diagnostic Exosome Biomarker Introduction
11.13.4 ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.13.5 ReNeuron Group Recent Developments
11.14 Therapeutic Solutions International
11.14.1 Therapeutic Solutions International Company Details
11.14.2 Therapeutic Solutions International Business Overview
11.14.3 Therapeutic Solutions International Diagnostic Exosome Biomarker Introduction
11.14.4 Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2017-2022)
11.14.5 Therapeutic Solutions International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Membrane-bound Proteins
Table 3. Key Players of Soluble Proteins
Table 4. Key Players of Noncoding RNA
Table 5. Key Players of Others
Table 6. Global Diagnostic Exosome Biomarker Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Diagnostic Exosome Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Diagnostic Exosome Biomarker Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Diagnostic Exosome Biomarker Market Share by Region (2017-2022)
Table 10. Global Diagnostic Exosome Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Diagnostic Exosome Biomarker Market Share by Region (2023-2028)
Table 12. Diagnostic Exosome Biomarker Market Trends
Table 13. Diagnostic Exosome Biomarker Market Drivers
Table 14. Diagnostic Exosome Biomarker Market Challenges
Table 15. Diagnostic Exosome Biomarker Market Restraints
Table 16. Global Diagnostic Exosome Biomarker Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Diagnostic Exosome Biomarker Revenue Share by Players (2017-2022)
Table 18. Global Top Diagnostic Exosome Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Exosome Biomarker as of 2021)
Table 19. Ranking of Global Top Diagnostic Exosome Biomarker Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Diagnostic Exosome Biomarker Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diagnostic Exosome Biomarker Product Solution and Service
Table 23. Date of Enter into Diagnostic Exosome Biomarker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2017-2022)
Table 27. Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2023-2028)
Table 29. Global Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Diagnostic Exosome Biomarker Revenue Share by Application (2017-2022)
Table 31. Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Diagnostic Exosome Biomarker Revenue Share by Application (2023-2028)
Table 33. North America Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Diagnostic Exosome Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Diagnostic Exosome Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Diagnostic Exosome Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Diagnostic Exosome Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Diagnostic Exosome Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Diagnostic Exosome Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Diagnostic Exosome Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Diagnostic Exosome Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Diagnostic Exosome Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Diagnostic Exosome Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Diagnostic Exosome Biomarker Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Diagnostic Exosome Biomarker Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Diagnostic Exosome Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Diagnostic Exosome Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Diagnostic Exosome Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Diagnostic Exosome Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Diagnostic Exosome Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 63. 101Bio Company Details
Table 64. 101Bio Business Overview
Table 65. 101Bio Diagnostic Exosome Biomarker Product
Table 66. 101Bio Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 67. 101Bio Recent Developments
Table 68. AMS Biotechnology Company Details
Table 69. AMS Biotechnology Business Overview
Table 70. AMS Biotechnology Diagnostic Exosome Biomarker Product
Table 71. AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 72. AMS Biotechnology Recent Developments
Table 73. BioRegenerative Sciences Company Details
Table 74. BioRegenerative Sciences Business Overview
Table 75. BioRegenerative Sciences Diagnostic Exosome Biomarker Product
Table 76. BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 77. BioRegenerative Sciences Recent Developments
Table 78. Cell Guidance Systems Company Details
Table 79. Cell Guidance Systems Business Overview
Table 80. Cell Guidance Systems Diagnostic Exosome Biomarker Product
Table 81. Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 82. Cell Guidance Systems Recent Developments
Table 83. Codiak BioSciences Company Details
Table 84. Codiak BioSciences Business Overview
Table 85. Codiak BioSciences Diagnostic Exosome Biomarker Product
Table 86. Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 87. Codiak BioSciences Recent Developments
Table 88. Evomic Science Company Details
Table 89. Evomic Science Business Overview
Table 90. Evomic Science Diagnostic Exosome Biomarker Product
Table 91. Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 92. Evomic Science Recent Developments
Table 93. ExoCyte Therapeutics Company Details
Table 94. ExoCyte Therapeutics Business Overview
Table 95. ExoCyte Therapeutics Diagnostic Exosome Biomarker Product
Table 96. ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 97. ExoCyte Therapeutics Recent Developments
Table 98. Bio-Techne Company Details
Table 99. Bio-Techne Business Overview
Table 100. Bio-Techne Diagnostic Exosome Biomarker Product
Table 101. Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 102. Bio-Techne Recent Developments
Table 103. Exovita biosciences Company Details
Table 104. Exovita biosciences Business Overview
Table 105. Exovita biosciences Diagnostic Exosome Biomarker Product
Table 106. Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 107. Exovita biosciences Recent Developments
Table 108. Immune Therapy Holdings Company Details
Table 109. Immune Therapy Holdings Business Overview
Table 110. Immune Therapy Holdings Diagnostic Exosome Biomarker Product
Table 111. Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 112. Immune Therapy Holdings Recent Developments
Table 113. Lonza Company Details
Table 114. Lonza Business Overview
Table 115. Lonza Diagnostic Exosome Biomarker Product
Table 116. Lonza Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 117. Lonza Recent Developments
Table 118. Norgen Biotek Company Details
Table 119. Norgen Biotek Business Overview
Table 120. Norgen Biotek Diagnostic Exosome Biomarker Product
Table 121. Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 122. Norgen Biotek Recent Developments
Table 123. ReNeuron Group Company Details
Table 124. ReNeuron Group Business Overview
Table 125. ReNeuron Group Diagnostic Exosome Biomarker Product
Table 126. ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 127. ReNeuron Group Recent Developments
Table 128. Therapeutic Solutions International Company Details
Table 129. Therapeutic Solutions International Business Overview
Table 130. Therapeutic Solutions International Diagnostic Exosome Biomarker Product
Table 131. Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2017-2022) & (US$ Million)
Table 132. Therapeutic Solutions International Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Exosome Biomarker Market Share by Type: 2021 VS 2028
Figure 2. Membrane-bound Proteins Features
Figure 3. Soluble Proteins Features
Figure 4. Noncoding RNA Features
Figure 5. Others Features
Figure 6. Global Diagnostic Exosome Biomarker Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diagnostic Exosome Biomarker Report Years Considered
Figure 11. Global Diagnostic Exosome Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Diagnostic Exosome Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Diagnostic Exosome Biomarker Market Share by Region: 2021 VS 2028
Figure 14. Global Diagnostic Exosome Biomarker Market Share by Players in 2021
Figure 15. Global Top Diagnostic Exosome Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Exosome Biomarker as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Exosome Biomarker Revenue in 2021
Figure 17. North America Diagnostic Exosome Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Diagnostic Exosome Biomarker Market Size Market Share by Type (2017-2028)
Figure 19. North America Diagnostic Exosome Biomarker Market Size Market Share by Application (2017-2028)
Figure 20. North America Diagnostic Exosome Biomarker Market Size Share by Country (2017-2028)
Figure 21. United States Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Diagnostic Exosome Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Diagnostic Exosome Biomarker Market Size Market Share by Type (2017-2028)
Figure 25. Europe Diagnostic Exosome Biomarker Market Size Market Share by Application (2017-2028)
Figure 26. Europe Diagnostic Exosome Biomarker Market Size Share by Country (2017-2028)
Figure 27. Germany Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Diagnostic Exosome Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Diagnostic Exosome Biomarker Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Diagnostic Exosome Biomarker Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Diagnostic Exosome Biomarker Market Size Share by Region (2017-2028)
Figure 37. China Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Diagnostic Exosome Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Diagnostic Exosome Biomarker Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Diagnostic Exosome Biomarker Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Diagnostic Exosome Biomarker Market Size Share by Country (2017-2028)
Figure 47. Mexico Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Diagnostic Exosome Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Diagnostic Exosome Biomarker Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Diagnostic Exosome Biomarker Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Diagnostic Exosome Biomarker Market Size Share by Country (2017-2028)
Figure 53. Turkey Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Diagnostic Exosome Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. 101Bio Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 57. AMS Biotechnology Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 58. BioRegenerative Sciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 59. Cell Guidance Systems Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 60. Codiak BioSciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 61. Evomic Science Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 62. ExoCyte Therapeutics Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 63. Bio-Techne Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 64. Exovita biosciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 65. Immune Therapy Holdings Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 66. Lonza Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 67. Norgen Biotek Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 68. ReNeuron Group Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 69. Therapeutic Solutions International Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
